ArticlePain medicine (Malden, Mass.)2026
Prediction of opioid use disorder among patients with chronic non-cancer pain receiving long-term opioid therapy.
Article in Pain medicine (Malden, Mass.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectiveAssessing opioid use disorder risk in patients prescribed long-term opioid therapy for management of chronic non-cancer pain is critical for prevention and early intervention.
designCase-control study.
settingPain management and primary care clinics, and substance use treatment facilities. SUBJECTS: Participants are 1300 patients with chronic non-cancer pain (59.68% women; mean age = 49.03 years), 409 of whom developed opioid use disorder.
methodsWe compared the performance of 3 machine learning models that used the Opioid Risk Tool for Opioid Use Disorder alone with those that incorporated an expanded set of clinical predictors.
resultsThe Opioid Risk Tool for Opioid Use Disorder showed strong performance (precision = 0.91; specificity = 0.96). Models that incorporated additional predictors showed improved performance on precision-recall area under the curve and F1 scores, particularly the random forest and eXtreme Gradient Boosting models. Aside from the Opioid Risk Tool for Opioid Use Disorder, the most important features in the expanded models were nicotine dependence, marital status, opioid misuse behaviors, and pain interference and catastrophizing.
conclusionsA stepwise approach that employs the Opioid Risk Tool for Opioid Use Disorder as a preliminary screener followed by a more in-depth assessment of clinical predictors among high-risk individuals may offer a feasible strategy to optimize efficiency and precision in risk stratification. Future work should refine and validate this framework in diverse population and care settings, as well as examine its integration into clinical workflow to enhance the identification of chronic non-cancer pain patients at risk for opioid use disorder.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.